Related Experiment Video
Updated: Jul 16, 2026

08:17
Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
Laparoscopic insertion of gastric electrodes for electrical stimulation
Fred Brody1, Arthur Nam, Elizabeth Drenon
1Department of General Surgery, The George Washington University Medical Center, Washington, DC 20037, USA. fbrody@mfa.gwu.edu
Summary
Laparoscopic insertion of gastric electrical stimulation wires offers a safe and effective treatment for refractory gastroparesis. This minimally invasive technique provides symptomatic relief without perioperative mortality.
Area of Science:
- Minimally Invasive Surgery
- Gastroenterology
- Medical Devices
Background:
- Refractory gastroparesis significantly impacts patient quality of life.
- Traditional surgical implantation of gastric electrical stimulation (GES) wires requires laparotomy.
- GES offers symptomatic relief for patients with severe gastroparesis.
Purpose of the Study:
- To describe and illustrate the laparoscopic technique for implanting GES wires.
- To evaluate the safety and efficacy of laparoscopic GES wire insertion.
- To assess outcomes in patients undergoing laparoscopic GES implantation.
Main Methods:
- A detailed description of the laparoscopic technique using four ports.
- Intraoperative endoscopy for lead placement verification.
- Data collection on patient demographics, operative details, and postoperative morbidities for 31 consecutive patients.
Main Results:
- All 31 procedures were successfully completed laparoscopically with a mean operative time of 114.4 minutes.
- No perioperative mortality occurred.
- Postoperative complications included two cases of cellulitis and two generator repositionings due to pain; no hardware removal was necessary.
Conclusions:
- Laparoscopic insertion of GES wires is a safe and effective alternative to laparotomy for treating refractory gastroparesis.
- The technique is feasible even in patients with prior abdominal surgery.
- Further long-term follow-up and multicenter trials are ongoing to confirm efficacy.